{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:02:20Z","timestamp":1791349340417,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health\/National Eye Institute","award":["EY014702"],"award-info":[{"award-number":["EY014702"]}]},{"name":"National Institutes of Health\/National Eye Institute","award":["EY025528"],"award-info":[{"award-number":["EY025528"]}]},{"name":"Massachusetts Lions Organization"},{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["SAF2012-35562"],"award-info":[{"award-number":["SAF2012-35562"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIBER for Diabetes and Associated Metabolic Diseases"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.exer.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T14:47:05Z","timestamp":1439909225000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy"],"prefix":"10.1016","volume":"140","author":[{"given":"Sumon","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayon","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2015.08.010_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2006.08.041","article-title":"Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries","volume":"193","author":"Alvarez de Sotomayor","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.exer.2015.08.010_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2004.07.046","article-title":"Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas","volume":"498","author":"Ayalasomayajula","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2015.08.010_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00125-003-1043-6","article-title":"A\u00a0study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose","volume":"46","author":"Beltramo","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2015.08.010_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00125-001-0761-x","article-title":"Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations","volume":"45","author":"Beltramo","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2015.08.010_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vph.2006.01.004","article-title":"Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1","volume":"44","author":"Chen","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.exer.2015.08.010_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.11646","article-title":"Significance of COX-2 expression in human renal cell carcinoma cell lines","volume":"108","author":"Chen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.exer.2015.08.010_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2015.08.010_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1167\/iovs.08-2377","article-title":"Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats","volume":"50","author":"Cherian","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.08.010_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2015.08.010_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2015.08.010_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2337\/diabetes.49.4.662","article-title":"Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats","volume":"49","author":"Evans","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2015.08.010_bib12","article-title":"Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-\u03baB activity","author":"Garcia-Ram\u00edrez","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.exer.2015.08.010_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2015.08.010_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2010.03.043","article-title":"PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity","volume":"394","author":"Hou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2015.08.010_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina","volume":"158","author":"Joussen","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2015.08.010_bib16","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2015.08.010_bib17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2015.08.010_bib18","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.exer.2015.08.010_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.exer.2007.01.009","article-title":"Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway","volume":"84","author":"Kim","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2015.08.010_bib20","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/j.1582-4934.2008.00484.x","article-title":"Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension","volume":"13","author":"Li","year":"2009","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.exer.2015.08.010_bib21","first-page":"1109","article-title":"ERK1\/2\/COX-2\/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes","volume":"20","author":"Li","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2015.08.010_bib22","article-title":"Effect of inhibiting high glucose-induced upregulation of ECM on connexin 43 (Cx43) expression in retinal endothelial cells","author":"Moon","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.08.010_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156720209788970081","article-title":"Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier","volume":"6","author":"Mysiorek","year":"2009","journal-title":"Curr. Neurovascular Res."},{"key":"10.1016\/j.exer.2015.08.010_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diabetes.55.01.06.db05-0186","article-title":"Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability","volume":"55","author":"Oshitari","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2015.08.010_bib25","first-page":"1933","article-title":"Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats","volume":"39","author":"Robison","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.08.010_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF00418547","article-title":"Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats","volume":"39","author":"Roy","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2015.08.010_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.08.009","article-title":"Apolipoprotein A1 is overexpressed in the retina of diabetic patients","volume":"147","author":"Simo","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2015.08.010_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0140-6736(07)61608-0","article-title":"Fenofibrate for diabetic retinopathy","volume":"370","author":"Simo","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2015.08.010_bib29","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.2174\/0929867311320260009","article-title":"Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives","volume":"20","author":"Simo","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.exer.2015.08.010_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Simo","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2015.08.010_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2015.08.010_bib32","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1167\/iovs.13-11763","article-title":"Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells","volume":"54","author":"Tien","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.08.010_bib33","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2015.08.010_bib34","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1167\/iovs.11-7282","article-title":"Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability","volume":"52","author":"Trudeau","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.08.010_bib35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00125-011-2089-5","article-title":"Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1beta by suppressing AMP-activated protein kinase (AMPK) activation","volume":"54","author":"Villarroel","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2015.08.010_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2015.08.010_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00109-007-0257-3","article-title":"Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose","volume":"86","author":"Zanetti","year":"2008","journal-title":"J.\u00a0Mol. Med. Berl."},{"key":"10.1016\/j.exer.2015.08.010_bib38","doi-asserted-by":"crossref","first-page":"e76836","DOI":"10.1371\/journal.pone.0076836","article-title":"Fenofibrate attenuated glucose-induced mesangial cells proliferation and extracellular matrix synthesis via PI3K\/AKT and ERK1\/2","volume":"8","author":"Zeng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2015.08.010_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11892-011-0198-7","article-title":"AGEs, RAGE, and diabetic retinopathy","volume":"11","author":"Zong","year":"2011","journal-title":"Curr. Diabetes Rep."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T23:41:02Z","timestamp":1668555662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483515300063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":39,"alternative-id":["S0014483515300063"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2015.08.010","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}